A Proposal by the U.S. Food and Drug Administration for Reliance on Single Institutional Review Boards: Proceed Only With Caution. Ann Intern Med 2024 Mar;177(3):383-384
Date
02/12/2024Pubmed ID
38346309DOI
10.7326/M23-2152Scopus ID
2-s2.0-85188479399 (requires institutional sign-in at Scopus site)Author List
Spellecy R, Thompson N, Nattinger ABAuthors
Ann B. Nattinger MD, MPH Associate Provost, Professor in the Medicine department at Medical College of WisconsinNathan Thompson MD Associate Professor in the Pediatrics department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Ethics Committees, ResearchHumans
United States
United States Food and Drug Administration
